The Concept of Targeted Protein Degradation
Targeted protein degradation is a novel approach that focuses on eliminating disease-causing proteins rather than just inhibiting them. This method utilizes the cell's natural protein degradation machinery to mark and dispose of specific target proteins. By acting as molecular matchmakers, degraders bring together an E3 ligase and a disease-causing protein, enabling the E3 ligase to tag the target protein for disposal by the proteasome.
Advantages of Degraders over Inhibitors
Degraders offer several advantages over traditional small molecule inhibitors. They can overcome resistance, eliminate dysregulated proteins, exhibit catalytic action, and target undruggable proteins. Compared to genetic therapies, degraders are small molecule drugs that can be taken orally, making them more accessible and avoid the need for genetic alterations or infusions.
Potential Applications in Various Diseases
While the focus is currently on cancer and autoimmune diseases, the application of degrader-based medicines extends to a wide range of medical conditions. This technology shows promise in treating not only cancer and autoimmune diseases but also metabolic disorders and nervous system disorders. Nurix is dedicated to exploring the full potential of this disease-agnostic technology to provide innovative treatments for a diverse array of medical conditions.
Stay Ahead in Today’s Competitive Market!
Unlock your company’s full potential with a Virtual Delivery Center (VDC). Gain specialized expertise, drive
seamless operations, and scale effortlessly for long-term success.
Book a Meeting to Avail the Services of Nurix